Versatile drug testing device

ABSTRACT

A versatile drug testing device (a lateral flow diagnostic testing device) includes a flat transparent carrier with a top and a bottom with the carrier having a series of independent parallel grooves formed therein running from adjacent to the top to adjacent to the bottom of the carrier, each groove having a first opening and a second opening above the first opening therein adjacent to the bottom of the carrier, at least one drug test strip installed in one of said grooves with its absorbent pad contiguous to the openings and a cover layer attached to the carrier operable to sealing close each of said grooves whereby the bottom of the device can be immersed in a specimen of “urine”, “body fluid” or “other biological specimen” to wet the pad of the at least one test strip though the ingress of the specimen though the associated openings and the test results on the test strip can be easily viewed through the transparent carrier. Because of the unique construction the device will give accurate reading if temporarily immersed in the specimen or left in the specimen for an extended period of time, making it very user friendly.

BACKGROUND OF THE INVENTION

The availability of drugs in the workplace and, in the general population, is pervasive. Employers and others, such as government agencies, general contractors, sports groups and, particularly transportation companies, often utilize drug screening, out of necessity, for both conditions of employment and to ensure safety in the workplace. However, it is impractical to have doctors perform each drug screening on site on a routine basis and also employing a doctor for such tasks is prohibitively expensive.

As a result the various commercial devices have been developed for drug screening in the field (on site) by employers and others which provide near instantaneous test results when liquid samples are collected in such devices. For example, see U.S. Pat. No. 5,403,551 entitled “Assaying Device and Container for In Field Analysis of a Specimen and Later Shipment of the Unadulterated Specimen” issued to Galloway, U.S. Pat. Nos. 6,805,838; 6,805,837; and 6,497,843 issued to Tydings, all entitled “Assaying Device and Method for In-Field Urinalysis”. Other patents for such devices included U.S. Pat. No. 6,726,879 issued to Ng et al. See also U.S. Pat. No. 6,140,136 issued to Lee teaching a similar device.

Along with cups the prior art teaches the use of test cassettes, where the test strips lay in a horizontal plane secured to a test bed and the technician places a few drops of a specimen onto the sample area of the individual test strips in the cassette. These test cassettes have reagent test strips attached thereto that change color in the presence of certain chemicals, in this case drugs.

In other embodiments test cassettes can be manufactured so that the ends of the test strips can be submerged into the specimen collection container holding a liquid the specimen. These cassettes are often referred to as dippers due to the step, during use, of submerging them in a liquid specimen, see for example U.S. Pat. No. 7,222,547 issued to Alley.

In general the above referenced devices are adapted to bring a small portion of a liquid specimen, such as a urine sample which is collected from an individual, into contact with test strips containing reagents which are responsive to the presence of drugs, such as amphetamines, cocaine, morphine, PCP, THC and/or their metabolites. Typically such reagents include, but are not limited to, colloidal gold coated sheep polyclonal anti-amphetamine, mouse monoclonal anti-benzoyl ecgonine, polyclonal rabbit anti-morphine-3 glucuronide, mouse monoclonal anti-cannabinoid or mouse monoclonal anti-phencyclidine, appropriate drug or drug analog conjugates, and immobilized antisera.

Typically the test strips have a top portion with a selected reagent and an absorbent sample pad at the bottom. Inside the strip is an absorbent membrane and a reaction membrane in communication with the absorbent pad at the bottom. When the- absorbent sample pad contacts urine, the urine will wick- through the conjugate pad to the reagent (disposed on the reaction membrane) resulting in a positive or negative indication on the surface of the strip; the indication may be one line for positive and two lines for a negative or vice verse, e.g., for large molecule tests such as hormone test, one line is negative, two line is positive. Such test strips are commercially available from companies who have FDA clearance for the same, see FDA web site www.FDA.gov for the names of such companies.

In the past problems have been experienced with flooding of the test strips by the urine samples. Devices such as taught in U.S. Pat. No. 5,403,551 issued to Galloway and also in other patents, use separate compartments to limit the amount of liquid specimen which comes in contact with the test strips. As another example, see U.S. Pat. No. 6,726,879 issued to Ng et al which uses separate chambers to limit the amount of specimen that comes in contact the test strips, the patent pointing out that it is highly desirable to limit the contact of a urine sample with the reagent portion of the strips. To this end U.S. Pat. No. 6,397,620 issued to Lee et al, as well as some of the Tyding's patents referenced, supra, employ a vertical surface in a urine collection cup having a wicking membrane disposed thereon so that the wicking membrane conveys urine from the bottom of the cup to the absorbent sample pads of the test strips located at the top of the vertical surface via capillary action. Such arrangements are adapted to avoid flooding the test strip with the urine sample, in that case, which can invalidate the test results.

Problems also exist in situations where an inadequate amount of liquid specimen is absorbed by the test strip. Too little and too much of the specimen can affect the reliability of test results.

Products like the versatile device of this invention, currently in the market place, require the devices to be dipped in the specimen and submerged for a specific time specified by the manufacturer. This dwell time ensures the specimen saturates the wicking pad. The novel device, of the present invention, requires only a quick dip (a second or two) to activate the test, wherefore no dwell time is required to obtain an accurate test.

When specimen volume is limited, products currently available are hard to use. In the novel device of the instant invention a tester can use transfer pipet by adding drops of specimen into an opening in the device to activate the testing with reliable results.

Various prior art devices of the types described above can be viewed at http://www.rapidxams.com, illustrating drug check cups, cassettes and dip or dipper units.

It is an object of the present invention to provide a novel drug testing device which eliminates flooding of the test strips when a carrier containing the strips is submerged in a liquid specimen for either temporarily or for an extended period of time, the submersion time not being critical.

Another object is a provision of a novel drug testing device that ensures more accurate and positive test results when using conventional drug test strips because the novel device requires no required (or specificied) submersion period.

In addition the novel device includes a well below its lower opening that serves as a “reservoir” to store enough specimen for a reliable test even after a quick dip in a liquid specimen which feature expedites and simplifies testing making the novel device user friendly.

Still another object is the provision of an improved drug testing device that is economical to construct without sacrificing its drug testing reliability.

Another object is the provision of a construction that insures an adequate sample of a liquid specimen engages each test strip in the device to provide reliable testing without flooding the test strip.

It is also an object to provide an improved drug testing device which can provide reliable test results with limited quantities of a liquid specimen.

It is a general object of the present invention to provide an assaying device which is capable of easily collecting and testing a liquid specimen, such a urine, while avoiding many of the problems experienced by prior art devices now available in the market place.

It is also a object to proved a novel device is constructed of transparent material which provides an improved viewing area of the test strips and which also allows multiple tests to be performed on a single or strip. (e.g. 2 to 3 test can be performed on a single test strip).

SUMMARY OF THE INVENTION

An improved drug testing device includes a flat transparent carrier with a top and a bottom with the carrier having a series of independent parallel grooves formed therein running from adjacent to the top to adjacent to the bottom of the carrier, with each groove having a first opening and a second opening above the first opening therein in the trough of the groove adjacent to the bottom of the carrier, at least one test strip installed in one of said grooves with its absorbent sample pad contiguous to the openings in its associated groove and a cover layer attached to the carrier in a manner operable to sealing close all of said grooves whereby the bottom of the carrier can be temporarily or permanently dipped into a liquid specimen to wet the sample pad of the at least one test strip though the ingress of such specimen through the associated openings and the indications on the at least one test strip can viewed through the transparent carrier.

Typically the test strips are approximately 1.4 mm in thickness and the depth of each groove is about 1.5 mm. As a result the cover layer, when it includes glue on its entire contract surface for attaching it to the carrier 21, will also secure the test strip in its respective groove by adhering to the back of a test strip located in any groove. Further since the width of each groove is only slightly larger than the width of a test strip, the amount of unoccupied volume in each groove with a test strip therein and with the cover layer attached is limited and fluid ingress to the sample pad of the test strip can only occur through the two openings porting each groove.

Of course the carrier can have multiple test strips and as many independent grooves as desired as long as the number or grooves does not make the carrier to cumbersome to use in the field.

BRIEF DESCRIPTION OF THE DRAWINGS

The above-mentioned features and objects of the present invention are illustrated in the following description taken in conjunction with the accompanying drawings wherein like reference numerals denote like elements and in which:

FIG. 1. is an perspective of the novel drug testing device with the end cap removed illustrating its principal components;

FIG. 2 is a an exploded perspective of the device shown in FIG. 1 illustrating the construction of device;

FIG. 3 is a cross-section along line 3-3 shown in FIG. 1; and

FIG. 4 is an cross-section of a test strip that can be employed with the current device.

DETAILED DESCRIPTION OF THE INVENTION

Referring to FIG. 1 the novel drug testing device 20 is illustrated. It includes a transparent rectangular carrier 21 having a front face 30, a back face 31, a top 22 and a bottom 23. As can be seen in FIG. 2, the transparent carrier has a series of independent, parallel grooves 24, 25, 26, 27 and 28 formed in its rear or back face 31 which extend from a point adjacent to the top of the carrier to a point adjacent to the bottom of the carrier. While only five grooves are illustrated, the carrier can include more or less grooves depending on the number of test strips 35 which are to be employed. In FIG. 1 the test strips 35, one assembled in each groove, are easily viewable through the transparent carrier which can injuction molded. In addition, each groove includes opposed lugs 32 extending into the groove near the top and bottom ends of the groove. These opposed lugs squeeze the sides of test strips when installed enough to maintain the location of the test strips in its associated groove when the unit is assembled.

The front face 30 of the carrier 20 is smooth, except for the two openings in each groove (grooves 24, 25, 26, 7 and 28). The base opening 40 of each groove is located adjacent to the bottom 23 of the carrier 20 where it has fluid communication with its associated groove. It is shown as a rectangular window in the FIGS. 1 and 2. Just above the base opening is a bleed port 41, which is typically a round aperture, which also has communication with its associated groove and is located between 4 and 6 mm above the top of the base opening.

The presence of base opening 40 and its adjacent bleed port 41 is important to the proper functioning the novel - device 20. In this regard, when the device 20 is completely constructed, as hereinafter described, and submerged into a liquid specimen or sample, a portion of the specimen will ingress though the base opening and trapped air at the bottom of the groove will bleed or vent through the bleed port ensuring -the sample pad 44 (see FIG. 4) of the test strip 35 contiguous to these opening is fully wetted with the specimen. Such wetting of the sample pad of the test strip occurs almost instantaneously in the current device and it is not necessary for a user to be critical of the time that the bottom of the carrier is submerged in the liquid specimen nor the actual depth of the bottom 23 of the carrier in the specimen which are often critical requirements in the prior art devices. Such prior art devices typically have markings thereon for the insertion depth of the unit and specified the time for the unit must be submerged to obtain a reliable test.

In the novel device 20 of this invention, its improved function is achieved by a differential of pressure of the liquid at the bleed port and the base opening when the bottom 23 of the carrier 21 is submerged in a specimen. This differential can be generalized as, at the base opening the pressure is P1=H1*D (depth of window opening in the fluid×density of fluid) and at the bleed port the pressure is P2=H2*D (depth of the aperture in the fluid×density of the fluid). As H2 is smaller than H1 there is a differential which can be expressed as ▴P=P1−P2. As a result, the higher pressure at the base opening will cause fluid to enter the groove and expel any trapped air through the bleed port for better wetting of the absorbent sample pad of a test strip. As a result the novel device of this invention is more reliable than prior art devices of a similar type because it is more user friendly and requires less rigorous attention to detail when it is employed.

In addition, since the base opening 40 is several millimeters, from 2 to 4 millimeters, above the bottom of its associated groove, there is a small well 42 formed thereat, which will rapidly fill will a portion of the liquid specimen when the bottom 23 of the carrier 20 is submerged. While only a very small amount of specimen is trapped in the well, it is enough to activate the reagent on the test strip for a positive test, should inadequate wetting otherwise occur, such as may occur due to the surface tension of the specimen.

Referring FIG. 2, the exploded view of the components, the back -31 of the carrier 20 is shown where the parallel grooves 24, 25, 26, 27 and 28 are depicted formed in the transparent carrier. It is obvious that these grooves are closed at their top end 50 and bottom end 51 and that the base opening 40 is formed in the trough of each groove slightly above the bottom end of the carrier. Slightly above the base opening is the bleed port 41 which is typically between 3 to 6 millimeters above the base opening. The base opening is typically a rectangular opening with dimensions of 5 to 6 millimeters by 2 to 5 millimeters. If the bleed port is a circular aperture is will have a diameter from 2 to 4 mm.

Into the several grooves 24, 25, 26, 27 and 28 a drug test strip 35 is inserted so that its sample pad 44 is contiguous to the base opening and bleed port. If desired a spacing layer 37 can be added to the face of the test strip to increase the thickness of the test strip just above the location of the sample pad contiguous to the base opening and the bleed port. Its purpose of this layer is to limit the amount of specimen that travels up the groove by increasing the thickness of the test strip in this area to block the ingress of the liquid specimen and trap the air above the spacing layer both of which prevents flooding of test strip in the associated groove.

Referring now to FIG. 4 illustrating a typical test strip 35, it can be seen that it has a vinyl backing 43 on which an absorbent sample pad 44 is secured that feeds liquids deposited thereon by capillary action to a conjugate pad 45 that communicates with a membrane 46 on which a test reagent 47 and a control reagent 48 are located. Also illustrated on the test strip is the a spacing layer 37 which function has been described previously.

Again referring to FIG. 2 it can be seen that each of the test strips 35 employed is placed in an associated groove, and thereafter the cover or backing layer 60, having its contact surface 61 covered with glue, is assembled on the back 31 of the transparent carrier 20 so that it completely seals each groove whereby the only ingress to the test strip is through the base opening 40 and the bleed port 41 associated with each groove. In addition the cover or backing layer 60 will contact the back of the test strip placed in any of the grooves, securing the strips in place. When the cover of backing layer is glued to the back of each test strip in the assembled device, it is difficult to tamper (remove or change) any of the test strips without destroying the novel device. However in place of glue the backing layer can be welded to the back of the carrier 21 to seal the opening of each of the grooves on the back face of the carrier.

In the cross section shown in FIG. 3 it can be seen that test strip 35 takes up the majority of the volume of its associated groove when the cover or backing layer 60 closes the groove. As a result flooding of the test strip with the urine specimen will not occur due to trapped air above the spacing layer 37.

The location of the bleeding vent is designed and calculated depending on the size of the device. It is always below the gold conjugate pad 45 (see FIG. 4) so that fluid can enter the lower opening, wet the absorbent pad 44 to activate the testing process. The air pressure in the groove above the bleeding port will prevent the liquid from flowing further into the groove and above. Due to this limitation the delivery of the specimen above the bleeding port is through capillary action and is thus controlled. The groove cross-section, lower opening, bleeding port size and location, test strip specifications, are all correlated and designed.

As indicated the test strips employed in this novel device are conventional and can be purchased from various manufacturers

When not in use, a cap 62 is used to enclose the bottom of the carrier 20 to avoid contamination of the test strips 30. However, in the current design contamination of the test strips is less likely because the sample pads thereof are completely enclosed in the carrier, as illustrated.

Cap 62 is used to enclose the bottom of the carrier 21 that contacts specimen after testing process to avoid contamination. Cap 62 can have two projections A and B (not shown) that extend from the opening of the cap and form guides to assist in assembling the cap on the bottom of the carrier 20 to make it more user friendly. 

1. The novel testing device comprises: a transparent carrier with a front, back, top and a bottom; a plurality of independent parallel grooves formed in the back of said carrier each groove extending from adjacent to said top to adjacent to said bottom of said carrier; each of said grooves having a base opening and a bleed opening above such base opening in the trough of said associated groove, said openings in each groove being adjacent to said bottom of said carrier; at least one test strip installed in one of said grooves with its absorbent sample pad located contiguous to said openings; and a cover layer attached to said back of said carrier in a manner operable to sealing close each of said grooves whereafter the bottom of said carrier can be immersed into a liquid specimen to wet the sample pad of said at least one test strip through the ingress of such specimen though said associated openings in its associated groove and changes in indications on said at least one test strip can viewed through said transparent carrier.
 2. The novel device defined in claim 1 wherein a plurality of test strips are assembled the grooves formed in the carrier before the cover layer is attached to the back of said carrier to seal each of the grooves.
 3. The novel device defined in claim 1 wherein the cover layer is glued to the back of the carrier to sealing close each of the grooves formed in the back of said carrier.
 4. The novel device defined in claim 1 wherein the cover layer is welded to the back of the carrier to sealing close each of the grooves formed in the back of said carrier.
 5. The novel device defined in claim 1 wherein each of the grooves formed in the back of the carrier have inwardly projecting lugs near its top and bottom ends operable to stabilize the location of a test strip inserted in such groove.
 6. The novel device defined in claim 1 wherein the carrier is formed of transparent plastic material.
 7. The novel device defined in claim 3 wherein the cover layer is glued to the back of the carrier and secures said one test strip in its groove by adhering to the back of said test strip to prevent the removal of the latter.
 8. The novel device defined in claim 1 wherein a spacing layer operable to increase the thickness of the test strip is located above the openings in the associated groove containing said test strip and is operable to keep the liquid specimen from flooding said entire test strip.
 9. A novel drug testing device comprising: a transparent carrier having a top end, a bottom end, a front side and a back side; a plurality of independent parallel grooves formed in said back side extending from the adjacent to said top end to a point adjacent to said bottom end of said carrier; at least one drug test strip disposed in at least one of such grooves; a cover layer attached to said back side of said carrier operable to sealing close each of such grooves; a first opening in the front side of said carrier for each groove adjacent to the bottom end of said carrier operable to provide fluid communication to its associated groove; and a bleed port formed above each of said first openings operable to bleed air in the bottom of each groove when a portion of a fluid specimen enters the associated said first opening of its associated groove to ensure improved wetting of the sample pad of a test strip disposed in such groove.
 10. The novel drug testing device defined in claim 9 wherein each of such grooves includes a drug testing strip. 